CMA-200

N/A

Report date: 2025/09/01 14:24:18
NME

Base Information

Drug NameCMA-200
Drug Alias NameCMA200CMA 200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAutophagy stimulants
TargetsNot applicable
Therapy Area/IndicationsNeurodegenerative DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLife Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLife Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeurodegenerative DiseasesAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A